Showing results (3081-3090 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|June 25, 2013
Combinatorial approaches for the identification of brain drug delivery targetsCharles C Stutz, Xiaobin Zhang, Eric V ShustaCurrent Pharmaceutical Design|March 28, 2013
Systems biology approaches to pancreatic cancer detection, prevention and treatmentOsama M Alian, Philip A Philip, Fazlul H Sarkar, et al.Current Pharmaceutical Design|March 28, 2013
Proteomic-based analysis for identification of proteins involved in 5-fluorouracil resistance in hepatocellular carcinomaYi Tan, Shukui Qin, Xin Hou, et al.Current Pharmaceutical Design|March 28, 2013
Protein microarrays for studies of drug mechanisms and biomarker discovery in the era of systems biologyShun Tu, He-Wei Jiang, Cheng-Xi Liu, et al.Current Pharmaceutical Design|March 28, 2013
Erythropoietin: a neuroprotective agent in cerebral hypoxia, neurodegeneration, and epilepsyAmalia Merelli, Liliana Czornyj, Alberto LazarowskiCurrent Pharmaceutical Design|March 28, 2013
P-glycoprotein contributes to cell membrane depolarization of hippocampus and neocortex in a model of repetitive seizures induced by pentylenetetrazole in ratsJerónimo A Auzmendi, Sandra Orozco-Suárez, Ivette Bañuelos-Cabrera, et al.Current Pharmaceutical Design|March 28, 2013
Resveratrol: new avenues for a natural compound in neuroprotectionMercè Pallàs, David Porquet, Alberto Vicente, et al.Current Pharmaceutical Design|May 11, 2012
Radiolabeled small molecule inhibitors of VEGFR - recent advancesTorsten KniessCurrent Pharmaceutical Design|May 11, 2012
Recent advances in designing substrate-competitive protein kinase inhibitorsKi-Cheol Han, So Yeon Kim, Eun Gyeong YangCurrent Pharmaceutical Design|May 11, 2012
Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectivesMengzhu Xue, Xianwen Cao, Ye Zhong, et al.Pageof 1,008